Zoetis Inc.
Zoetis Inc. (0M3Q.L) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Zoetis Inc. (0M3Q.L), covering cash flow, earnings, and balance sheets.
Zoetis Inc. (0M3Q.L) Income Statement & Financial Overview
Explore comprehensive income reports for Zoetis Inc. 0M3Q.L, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $2.46B | $2.22B | $2.32B | $2.39B |
| Cost of Revenue | $649.00M | $622.00M | $707.00M | $701.00M |
| Gross Profit | $1.81B | $1.60B | $1.61B | $1.69B |
| Gross Profit Ratio | $0.74 | $0.72 | $0.69 | $0.71 |
| R&D Expenses | $172.00M | $157.00M | $186.00M | $167.00M |
| SG&A Expenses | $617.00M | $563.00M | $625.00M | $565.00M |
| Operating Expenses | $789.00M | $752.00M | $845.00M | $732.00M |
| Total Costs & Expenses | $1.44B | $1.37B | $1.55B | $1.47B |
| Interest Income | $0.00 | $23.00M | $27.00M | $23.00M |
| Interest Expense | $53.00M | $54.00M | $51.00M | $57.00M |
| Depreciation & Amortization | $0.00 | $119.00M | $123.00M | $121.00M |
| EBITDA | $1.02B | $983.00M | $911.00M | $1.06B |
| EBITDA Ratio | $0.42 | $0.44 | $0.39 | $0.44 |
| Operating Income | $1.02B | $846.00M | $765.00M | $920.00M |
| Operating Income Ratio | $0.42 | $0.38 | $0.33 | $0.39 |
| Other Income/Expenses (Net) | -$120.00M | -$36.00M | -$33.00M | -$46.00M |
| Income Before Tax | $902.00M | $810.00M | $732.00M | $874.00M |
| Income Before Tax Ratio | $0.37 | $0.36 | $0.32 | $0.37 |
| Income Tax Expense | $184.00M | $179.00M | $151.00M | $182.00M |
| Net Income | $718.00M | $631.00M | $581.00M | $682.00M |
| Net Income Ratio | $0.29 | $0.28 | $0.25 | $0.29 |
| EPS | $1.61 | $1.41 | $1.29 | $1.51 |
| Diluted EPS | $1.61 | $1.41 | $1.29 | $1.50 |
| Weighted Avg Shares Outstanding | $445.10M | $447.60M | $450.50M | $452.90M |
| Weighted Avg Shares Outstanding (Diluted) | $445.50M | $448.00M | $451.10M | $453.50M |
Over the last four quarters, Zoetis Inc. achieved steady financial progress, growing revenue from $2.39B in Q3 2024 to $2.46B in Q2 2025. Gross profit stayed firm with margins at 74% in Q2 2025 versus 71% in Q3 2024. Operating income totaled $1.02B in Q2 2025, maintaining a 42% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.02B. Net income rose to $718.00M, with EPS at $1.61. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan